So the farce that is the US drug approvals theatre continues as now Regeneron pulls out of testing advanced suffering COIVD-19 patients due to safety concerns:
https://www.reuters.com/article/us-health-coronavirus-regeneron-pharms-idUSKBN27F2AY
This follows of course the joke of Remdesivir:
https://www.sciencemag.org/news/2020/10/very-very-bad-look-remdesivir-first-fda-approved-covid-19-drug
Bar Dexamethasone and proning, and the results therein are not unequivocal, after 8 months we still have nothing to treat advanced sufferers and bear in mind 90% of mortalities have incidents of ARDS associated. What a sorry state of affairs the world is in.
What a shame Mt Sinai and the NIH have been so tardy too during the biggest medical crisis in modern history. REM-L might be the only genuine treatment answer out there and we are stuck here waiting for recruitment, despite the US now having 100,000 cases a day.
- Forums
- ASX - By Stock
- MSB
- Elli Lilly and now Regeneron not treating advanced COIVD-19 sufferers
Elli Lilly and now Regeneron not treating advanced COIVD-19 sufferers
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
94.5¢ |
Change
-0.050(5.03%) |
Mkt cap ! $1.093B |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 94.5¢ | $1.911M | 1.970M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 109197 | 94.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
95.0¢ | 54896 | 54 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 109197 | 0.945 |
19 | 208228 | 0.940 |
13 | 104329 | 0.935 |
9 | 197393 | 0.930 |
5 | 510290 | 0.925 |
Price($) | Vol. | No. |
---|---|---|
0.950 | 52635 | 53 |
0.955 | 39384 | 19 |
0.960 | 102673 | 13 |
0.965 | 90218 | 8 |
0.970 | 62035 | 5 |
Last trade - 14.33pm 20/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |